Reaction

Vertigo Positional reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,725 reports · 44 co-occurring drugs

As of the last recalculation, Vertigo Positional appears in 1,725 FAERS reports alongside 44 co-occurring drug terms. The strongest observed disproportionality signal is MECLIZINE HCL 12.5MG (PRR 24.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Meclizine Hcl 12.5Mg	27	24.3	24.3
Meclizine Hcl 25Mg	27	24.3	24.3
Meclizine Hcl 12.5 Mg	27	24.3	24.3
Meclizine Hcl 25 Mg	27	24.3	24.3
Meclizine	28	21.0	21.1
Meclizine Hydrochloride	31	19.4	19.5
Erythromycin	26	17.0	17.0
Quinine	11	15.6	15.6
Ketoconazole	20	14.1	14.1
Ketoconazole Foam	17	14.0	14.0
Ketoconazole Cream, 2%	17	13.9	14.0
Cladribine	11	13.9	13.9
Oseltamivir	9	13.7	13.7
Drs. Clotrimazole	13	13.7	13.7
Family Wellness Clotrimazole	13	13.7	13.7
Clotrimazole Topical	13	13.7	13.7
Rizatriptan Benzoate	11	13.1	13.1
Abaloparatide	31	12.9	12.9
Clotrimazole	13	12.9	12.9
Cefazolin Sodium	12	12.1	12.1
Sucralfate Oral	14	12.0	12.0
Sucralfate Oral Suspension	14	11.9	11.9
Primidone	9	10.7	10.7
Cetirizine Hcl	8	10.6	10.6
Fluticasone Furoate	10	10.0	10.0
Mupirocin	11	9.9	9.9
Mupirocin Calcium	11	9.7	9.7
Dronedarone	8	9.5	9.5
Triamcinolone Acetonide Ointment Usp, 0.05%	16	8.3	8.3
Lanreotide Acetate	5	7.7	7.7
Calcium, Magnesium, Potassium, And Sodium Oxybates	5	7.0	7.0
Acalabrutinib	7	7.0	7.0
Triamcinolone Acetonide	17	6.7	6.7
Nilotinib	16	6.6	6.6
Ocrelizumab	32	6.3	6.3
Teduglutide	7	6.3	6.3
Fesoterodine Fumarate	5	5.6	5.6
Omalizumab	38	5.5	5.5
Fingolimod Hcl	34	4.8	4.8
Naltrexone Hydrochloride And Bupropion Hydrochloride	3	4.3	4.3
Siponimod	3	4.1	4.1
Peginterferon Beta-1A	4	3.7	3.7
Ranibizumab	7	3.2	3.2
Dalfampridine	18	3.0	3.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.